Ratings by Stephens (George Sellers)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/25/2026 | Establishment Labs Inc. | ESTA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/2/2026 | Glaukos Corporation | GKOS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/2/2025 | Glaukos Corporation | GKOS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/9/2024 | Cutera | CUTR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2024 | Teleflex | TFX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2024 | TransMedics Group | TMDX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/4/2024 | TransMedics Group | TMDX | New Coverage | Overweight (N/A) |
136.40 (93.97) |
-31.11% | Details | |
| 2/13/2024 | Enovis Corp | ENOV | New Coverage | Overweight (N/A) |
60.32 (26.50) |
-56.07% | Details | |
| 11/10/2023 | Apyx Medical Corp. | APYX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/8/2023 | Glaukos Corporation | GKOS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/10/2023 | Treace Medical Concepts Inc | TMCI | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/10/2023 | Anika Therapeutics | ANIK | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/4/2023 | STAAR Surgical | STAA | Maintain | Overweight (N/A) |
|
Details | ||
| 7/27/2023 | Teleflex | TFX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/14/2023 | Apyx Medical Corp. | APYX | New Coverage | Overweight (N/A) |
5.77 (3.15) |
-45.41% | Details | |
| 5/5/2023 | Teleflex | TFX | Maintain | Overweight (N/A) |
|
Details | ||
| 4/11/2023 | Paragon 28, Inc | FNA | New Coverage | Overweight (N/A) |
17.08 (12.00) |
-29.74% | Details | |
| 4/11/2023 | Treace Medical Concepts Inc | TMCI | New Coverage | Equal Weight (N/A) |
27.81 (4.56) |
-83.6% | Details | |
| 2/28/2023 | Establishment Labs Inc. | ESTA | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2023 | Teleflex | TFX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/28/2022 | Teleflex | TFX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/28/2022 | STAAR Surgical | STAA | Maintain | Overweight (N/A) |
|
Details | ||
| 12/28/2022 | Glaukos Corporation | GKOS | Maintain | Overweight (N/A) |
|
Details | ||
| 12/28/2022 | Establishment Labs Inc. | ESTA | Maintain | Overweight (N/A) |
|
Details | ||
| 12/28/2022 | Cutera | CUTR | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2022 | Teleflex | TFX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/14/2022 | Teleflex | TFX | New Coverage | Overweight (N/A) |
186.76 (135.86) |
-27.25% | Details | |
| 10/14/2022 | Establishment Labs Inc. | ESTA | New Coverage | Overweight (N/A) |
55.96 (75.36) |
34.67% | Details | |
| 10/14/2022 | Glaukos Corporation | GKOS | New Coverage | Overweight (N/A) |
52.13 (189.55) |
263.61% | Details | |
| 10/14/2022 | Anika Therapeutics | ANIK | New Coverage | Equal Weight (N/A) |
24.33 (21.26) |
-12.62% | Details | |
| 10/14/2022 | Cutera | CUTR | New Coverage | Overweight (N/A) |
44.89 (0.10) |
-99.78% | Details | |
| 10/13/2022 | STAAR Surgical | STAA | New Coverage | Overweight (N/A) |
70.34 (24.66) |
-64.94% | Details |
